(Total Views: 508)
Posted On: 03/05/2021 5:51:01 PM
Post# of 145883
CytoDyn's Phase 3 Trial Demonstrates Safety, a 24% Reduction in Mortality and Faster Hospital Discharge for Mechanically Ventilated Critically Ill COVID-19 Patients Treated with Leronlimab
(1)
(0)